I used to overeat, but now I can only manage two small meals a day, one reviewer explained
Dybvik JS, Svendsen M, Aune D
This extensive research timeline provides substantial evidence regarding both short-term efficacy and longer-term safety considerations, though ongoing studies continue to expand our understanding of this medication's full clinical profile
(2021) Safety of semaglutide, Frontiers in endocrinology , 12, p
For people with a diagnosed deficiency or a condition that impairs carnitine use, supplementation may be medically important
Together, they demonstrate the clinical viability of the GLP-1/glucagon dual-agonist concept and suggest that this mechanism class will be a significant addition to the metabolic disease treatment landscape alongside tirzepatide and emerging triple agonists like retatrutide